389 related articles for article (PubMed ID: 36100838)
1. RNA therapeutics: updates and future potential.
Zhang C; Zhang B
Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
[TBL] [Abstract][Full Text] [Related]
2. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
Germain ND; Chung WK; Sarmiere PD
Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
[TBL] [Abstract][Full Text] [Related]
3. The Limitless Future of RNA Therapeutics.
Damase TR; Sukhovershin R; Boada C; Taraballi F; Pettigrew RI; Cooke JP
Front Bioeng Biotechnol; 2021; 9():628137. PubMed ID: 33816449
[TBL] [Abstract][Full Text] [Related]
4. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
5. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC; Kowalski PS; Anderson DG
Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities for Nucleic Acid Therapeutics.
Corey DR; Damha MJ; Manoharan M
Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
[TBL] [Abstract][Full Text] [Related]
7. Synthetic RNA Therapeutics in Cancer.
Han Y; Shin SH; Lim CG; Heo YH; Choi IY; Kim HH
J Pharmacol Exp Ther; 2023 Aug; 386(2):212-223. PubMed ID: 37188531
[TBL] [Abstract][Full Text] [Related]
8. RNA therapeutics for metabolic disorders.
Vu TD; Lin SC; Wu CC; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():181-196. PubMed ID: 38359998
[TBL] [Abstract][Full Text] [Related]
9. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
10. Recent updates on therapeutic targeting of lipoprotein(a) with RNA interference.
Sekhar A; Kuttan A; Lange RA
Curr Opin Cardiol; 2024 Jul; 39(4):292-299. PubMed ID: 38547148
[TBL] [Abstract][Full Text] [Related]
11. RNA therapeutics for disorders of excretory system.
Vu TD; Nguyen MA; Jurgoński A; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():245-256. PubMed ID: 38360001
[TBL] [Abstract][Full Text] [Related]
12. The infinite possibilities of RNA therapeutics.
Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
[TBL] [Abstract][Full Text] [Related]
13. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
Bejar N; Tat TT; Kiss DL
Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
[TBL] [Abstract][Full Text] [Related]
14. RNA therapeutics history and future perspectives.
Duong HQ; Hoang MC; Nguyen TH; Ngo VL; Le VT
Prog Mol Biol Transl Sci; 2024; 203():99-114. PubMed ID: 38360008
[TBL] [Abstract][Full Text] [Related]
15. An introduction to RNA therapeutics and their potentials.
Bui NL; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():1-12. PubMed ID: 38359993
[TBL] [Abstract][Full Text] [Related]
16. RNA Therapeutics in Oncology: Advances, Challenges, and Future Directions.
MacLeod AR; Crooke ST
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S43-S59. PubMed ID: 28921648
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress and prospect in oligonucleotide therapeutics].
Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
[TBL] [Abstract][Full Text] [Related]
18. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
19. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases.
Pandey M; Ojha D; Bansal S; Rode AB; Chawla G
Mol Aspects Med; 2021 Oct; 81():101003. PubMed ID: 34332771
[TBL] [Abstract][Full Text] [Related]
20. Frameworks for transformational breakthroughs in RNA-based medicines.
Androsavich JR
Nat Rev Drug Discov; 2024 Jun; 23(6):421-444. PubMed ID: 38740953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
